Vergoeding 2018-2022 voor ATC-subgroep L04AX : Overige immunosuppressiva
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| L04AX01 Azathioprine (Imuran ®) | 2.031.500 | 2.018.500 | 1.900.700 | 1.713.800 | 1.635.400 |
| L04AX03 Methotrexaat (Injexate ®) | 22.301.000 | 21.885.800 | 21.861.100 | 20.240.900 | 19.076.500 |
| L04AX05 Pirfenidon (Esbriet ®) | 8.824.600 | 10.306.500 | 10.668.100 | 10.045.200 | 11.007.500 |
| L04AX07 Dimethylfumaraat (Skilarence ®) | 36.651.100 | 48.706.500 | 51.172.100 | 51.535.400 | 52.610.000 |
| L04AX09 Diroximelfumaraat (Vumerity ®) | . | . | . | . | 2.094.100 |
| Totaal | 69.808.200 | 82.917.300 | 85.602.000 | 83.535.300 | 86.423.500 |